Speaker illustration

Professor Francois Mach

University hospitals of Geneva, Geneva (Switzerland)

Prof. François Mach (h index >50), is an expert in the field of cardiology, in particular with regard to the development and progression of atherosclerosis diseases. After obtaining his MD at the University of Geneva he studied internal medicine and cardiology at Geneva University Hospital. He completed a post-doctoral fellowship in the laboratory of Prof. Peter Libby, Boston (1995-1999). Following his return to Switzerland in 2000, he became full Professor of cardiology, and in 2006 he was appointed Head of the cardiology department at Geneva University Hospital. Between 2012-14, he was the President of the Swiss Society of Cardiology. He is the author of more than 500 high impact factor publications and responsible of several Swiss cohorts of atherothrombotic patients, strongly implicated in clinical research in the field of prevention, especially lipidology. He was one of the 3 co-chairs of the ESC 2019 Lipid Guidelines, and is co-chairing of the ESC 2021 Prevention Guidelines.

Preventing atherosclerotic vascular disease throughout life: the earlier the better

Event: ESC Congress 2021 - The Digital Experience

Topic: Risk Factors and Prevention

Session type: Official Joint Session

Thumbnail

Late Breaking Science in Prevention 2

Event: ESC Congress 2019

Topic: Risk Factors and Prevention

Session type: Late-Breaking Science

Thumbnail

2019 ESC/EAS Guidelines on Dyslipidaemias

Event: ESC Congress 2019

Topic: Lipids

Session type: New ESC Guidelines

Thumbnail

Meet the Task Force of the 2019 ESC/EAS Guidelines on Dyslipidaemias

Event: ESC Congress 2019

Topic: Lipids

Session type: Special Session

Thumbnail

Professor Braunwald’s perspective on lipid lowering

Event: ESC Congress 2019

Topic: Lipids

Session type: Special Session

Thumbnail

Late Breaking Pharmacological Science

Event: ESC Congress 2018

Topic: Pharmacology and Pharmacotherapy

Session type: Late-Breaking Science

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb